Option Care Health Inc OPCH

$31.10 0.00 (—)

Valuation

Market cap
4,658,314,000
Revenue TTM
$5,649,520,000
Net income TTM
$207,590,000
PE ratio
19.66
Forward PE
18.28
Profit margin
3.67%
Debt to equity
0.92

Trading

Volume
5,013,400
Avg volume
3,999,350
Day's range
$31.09 – $31.17
Shares out
149,785,000
Stochastic %K
99%
Beta
0.58
Analysts
Sell
Price target
$28.41

Price

Company profile

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of i...

Show more

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Industry
Medical Care Facilities
Sector
Healthcare
Phone
312 940 2443
Website
https://optioncarehealth.com
Address
3000 Lakeside Drive, Suite 300N, Bannockburn, United States

Latest news

Stocktwits

HotDiamondFingers Oct 12, 11:47 AM
the deal spread, using $OPCH. on oct 6 the stock gapped about 33% on a report of a buyout. the deal was then announced at 32.05 a share, about 5.8 billion dollars including debt. it closed friday at 31.07, about 3% under the offer. that gap is the market pricing time and risk: close is expected in the first half of 2027 and shareholder and regulatory approvals are still needed. a signed price caps the upside, a report is only a probability.
0 replies
MikeyMcDermott Oct 11, 10:28 PM
$CCCS the sharps know the deal price. they would have bid it up to 9 AH Friday if the deal was going to be at 11-12 imo. My guess is another 20-30% premium from $8. Gets you to ~$10 zone ... maybe $10.50. That is $6.5 billion equity value on 616 million fully diluted shares, add 1.2 billion ish net debt for $7.7 billion deal all in ... vs $1.2B revs, 480 million EBITDA and maybe 350 million FCF. look at $OPCH similar story ... news broke after hours about a deal, stock was up 4-5 bucks, then deal price was another 10-15% from that level.
1 replies
KryptonResearch14 Oct 10, 6:35 PM
$OPCH Five firms have downgraded since the 5.8 billion dollar CD&R/McKesson cash buyout was announced, and every target landed on exactly 32.05, the deal price. UBS went Buy to Neutral (39 to 32.05); Jefferies went Buy to Hold (28 to 32.05). Nobody’s rating the company anymore. They’re rating the spread.
0 replies
Tickrtrends Oct 8, 2:19 PM
$OPCH screened as undervalued in this week's run. It ranks 7 of 112 Healthcare stocks by discount to our fair value estimate and has since closed 10 or more percentage points of the gap to our fair value estimate and remains more than 25% below it. Option Care Health carries P/E trailing 13x on Revenue TTM 5.69B. A screening result, not investment advice. Please research before acting. https://stocks.tickrtrends.com/opch?utm_source=dlvr.it&utm_medium=stocktwits
0 replies
KryptonResearch14 Oct 7, 5:02 PM
$OPCH The takeover talks closed into a done deal Tuesday: CD&R and McKesson signed a definitive agreement to take Option Care Health private at 32.05 a share, about 5.8 billion including debt. That is a roughly 37% premium to Monday's close, and the stock ran about 33% to just above 31. The structure is the interesting part. CD&R takes about 51% and control. McKesson pays about 1.4 billion for the other 49%, and gets a call right on CD&R's stake. This is not a straight strategic buyout. It is a PE-controlled deal with a strategic partner holding an option on full control. It fits a pattern. McKesson bought Precision Medicine Group for about 2.25 billion in August, and its oncology and multispecialty segment was up 33% last quarter. The drug distributor is systematically buying its way out of distribution into higher-margin care settings. Expected close in the first half of 2027. Tracking the shareholder vote and regulatory clearance from here.
0 replies
sSwSs Oct 7, 1:55 PM
$OPCH — Option Care Health's recent reports covered a mixed analyst sentiment alongside strong technical indicators and modest revenue growth. Recent analyses for Option Care Health (OPCH) examined its financial performance, noting a 1.9% year-over-year revenue growth and a 12.9% increase in quarterly earnings. Technical indicators showed a strong bullish trend with rapid price appreciation, though some indicators suggested the asset might be overextended. The news sentiment was mixed, with several downgrades offset by an upgrade and a significant stock price jump following news of a sale. Supportive points: Quarterly revenue growth of 1.9%. Quarterly earnings increase of 12.9%. Strong bullish technical trend with price above 50-day and 200-day SMAs. Concerns raised: RSI and MFI indicating overbought territory. Price trading above the upper Bollinger Band suggesting potential overextension. https://market-scanner.net/tickers/OPCH.US
0 replies
Market_Pulse_Report Oct 7, 12:00 PM
$OPCH
0 replies
CloudCapital Oct 7, 5:47 AM
$OPCH $31.00 | Mixed / Sideways RSI 83.7 (Overbought) MACD Bullish | Vol 12.1x MA20 $23.83 | MA50 $23.75 MA200 $26.44 S $20.68 | R $31.11 Cap $4.64B P/E 23.5 | Fwd 14.9 High Volatility / High Risk | $25.01 (-19.3%)
0 replies